In the context of cancer, mutations can be categorized as either driver or passenger mutations. Driver mutations are those that directly contribute to cancer progression by providing a growth advantage to the cells. In contrast, passenger mutations do not provide such an advantage but occur alongside driver mutations. Identifying driver mutations is essential for developing effective targeted therapies.
